Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation

Livongo looks strong in $355m IPO
Livongo priced its shares above their range to raise more than $355m, providing exits to Merck GHI, M12, Humana, Zaffre Investments and Echo Health Ventures.
Health Catalyst marshals $182m in IPO
Health Catalyst, which counts several care providers as investors, has raised $182m in its initial public offering, with its share price shooting up more than 50% on the first day of trading.
Phressia engages with public markets
Phreesia has raised more than $167m in proceeds after pricing shares above its range at $18, providing exits to BlueCross BlueShield, Ascension Health and Echo Health Ventures.
Mirum processes $75m IPO
Mirum Pharmaceuticals has raised $75m in its initial public offering that had an initial target of $86.3m and provided exits to Novo and Shire.
Fulcrum fulfils IPO dream
GlaxoSmithKline, Sanofi and 6 Dimensions Capital have all secured exits as the rare disease treatment developer raised $72m in its initial public offering.
Douyu wins $775m IPO game
Tencent-backed Douyu has successfully listed on Nasdaq after completing a $775m initial public offering that came after economic tensions forced a delay earlier this year.
IndiaMart takes stock of public market
IndiaMart, backed by Intel Capital and Brand Equity Treaty, has listed on the National Stock Exchange after raising $69m in its initial public offering.
Karuna caps off initial public offering
PureTech Health spinoff Karuna Therapeutics has upscaled its IPO to nearly $103m, after its shares rose by more than 50% in its first days of trading.

Other News

Morphic takes more money in $104m IPO
The corporate-backed small molecule therapeutic developer has boosted its initial public offering from $90m to nearly $104m.
Karuna kicks its way into public markets
PureTech Health-backed neuropsychiatric drug developer Karuna Therapeutics raised $89.2m in an upsized offering that followed $123m in venture capital.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
Adaptive Biotechnologies shapes $300m IPO
Shares in Adaptive Biotechnologies, backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences, soared more than 100% on its first day of trading.
The RealReal realises IPO plans in $300m offering
Novel Group-backed luxury goods marketplace The RealReal will raise $300m in an initial public offering in which it will float above its range.
Morphic shapes $90m initial public offering
Morphic began trading on the Nasdaq Global Market yesterday after issuing 6 million shares priced at $15 each, providing exits to AbbVie, GSK, Novo, Pfizer, Schrödinger and ShangPharma.

Editor's Picks

BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
Slack slides into public markets
The SoftBank, Comcast and Alphabet-backed communication platform developer saw its shares pop and its market cap climb nearly 50% to $19.5bn following its direct listing.
Uber arrives on public markets with $8.1bn
SoftBank Vision Fund is selling $245m of shares while PayPal is investing $500m in the ride hailing service, in the world's largest IPO since 2014.
Pinterest hits NYSE in $1.4bn IPO
Qualcomm-backed visual social media platform Pinterest floated above its range in an offering that will give it a market cap near $13bn.
test reg

Login